Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7)

Hypertension

Volumn 42, Issue 4 I, 2003, Pages 574-579

  Tallant, E Ann ^b   Clark, Michelle A ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Cyclic AMP; Muscle, smooth, vascular; Peptides; Prostacyclin; Protein kinases; Vasculature

Indexed keywords

ADENOSINE 3',5' PHOSPHOROTHIOATE; ADENYLATE CYCLASE; ANGIOTENSIN[1-7]; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADOLESCENT; ANGIOGENESIS; ANIMAL CELL; AORTA; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL INJURY; BLOOD VESSEL REACTIVITY; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; HEMOPERFUSION; HORMONE ACTION; MUSCLE GROWTH; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; CELL DIVISION; CELLS, CULTURED; CYCLIC AMP; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; PEPTIDE FRAGMENTS; PROSTAGLANDINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0141893551     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000090322.55782.30     Document Type: Article

References (47)

1. Dzau VJ, Gibbons GH. Endothelium and growth factors in vascular remodeling of hypertension. Hypertension. 1991;18(suppl III):III-115-III-121.
2. Weber H, Webb ML, Serafino R, Taylor DS, Moreland S, Norman J, Molloy CJ. Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms. Mol Endocrinol. 1994;8:148-158.
3. Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 1991;68:450-456.
4. Su EJ, Lombardi DM, Siegal J, Schwartz SM. Angiotensin induces vascular smooth muscle cell replication independent of blood pressure. Hypertension. 1998;31:1331-1337.
5. 1 receptor antagonist: effects on smooth muscle cell migration and proliferation after balloon catheter injury. Am J Pathol. 1991;139:1291-1296.
6. Powell JS, Clozel J-P, Muller RKM, Kuhn H, Hefti F, Hosang M, Baumgartner HR. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 1989;245:186-188.
7. Abell TJ, Richards AM, Ikram H, Espiner EA, Yandle T. Atrial natriuretic factor inhibits proliferation of vascular smooth muscle cells stimulated by platelet-derived growth factor. Biochem Biophys Res Commun. 1989;160:1392-1396.
8. Uehara Y, Ishimitsu T, Kimura K, Ishii M, Ikeda T, Sugimoto T. Regulatory effects of eicosanoids on thymidine uptake by vascular smooth muscle cells of rats. Prostaglandins. 1988;36:847-857.
9. Morisaki N, Kanzaki T, Motoyama N, Saito Y, Yoshida S. Cell cycle-dependent inhibition of DNA synthesis by prostaglandin 12 in cultured rabbit aortic smooth muscle cells. Atherosclerosis. 1988;71:165-171.
10. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1777.
11. Freeman EJ, Chisolm GM, Ferrario CM, Tallant EA. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension. 1996;28:104-108.
12. Tallant EA, Diz DI, Ferrario CM. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle. Hypertension. 1999;34(pt 2):950-957.
13. Strawn WB, Ferrario CM, Tallant EA. Angiotensin-(1-7) reduces smooth muscle growth after vascular injury. Hypertension. 1999;33(pt 2):207-211.
14. Campbell DJ, Kladis A, Duncan A-M. Nephrectomy, converting enzyme inhibition, and angiotensin peptides. Hypertension. 1993;22:513-522.
15. Kohara K, Brosnihan KB, Chappell MC, Khosla MC, Ferrario CM. Angiotensin-(1-7): a member of circulating angiotensin peptides. Hypertension. 1991;17:131-138.
16. Moriguchi A, Brosnihan KB, Kumagai H, Ganten D, Ferrario CM. Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene. Am J Physiol Regul Integr Comp Physiol. 1994;266:R1273-R1279.
17. Jaiswal N, Tallant EA, Jaiswal RK, Diz DI, Ferrario CM. Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved. J Pharmacol Exp Ther. 1993;265:664-673.
18. Jaiswal N, Jaiswal RK, Tallant EA, Diz DI, Ferrario CM. Alterations in prostaglandin production in spontaneously hypertensive rat smooth muscle cells. Hypertension. 1993;21:900-905.
19. Muthalif MM, Benter IF, Uddin MR, Harper JL, Malik KU. Signal transduction mechanism involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells. J Pharmacol Exp Ther. 1998;284:388-398.
20. Benter IF, Ferrario CM, Morris M, Diz DI. Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol. 1995;269:H313-H319.
21. Lowry OH, Rosebrough MJ, Farr AL, Randall RJ. Protein measurement with the Folin-phenol reagent. J Biol Chem. 1951;193:265-275.
22. Hara S, Morishita R, Tone Y, Yokoyama C, Inoue H, Kaneda Y, Ogihara T, Tanabe T. Overexpression of prostacyclin synthase inhibits growth of vascular smooth muscle cells. Biochem Biophys Res Commun. 1995;216:862-867.
23. Bayorh MA, Eatman D, Walton M, Socci RR, Thierry-Palmer M, Emmett N. A-779 attenuates angiotensin-(1-7) depressor response in salt-induced hypertensive rats. Peptides. 2002;23:57-64.
24. 2 and vascular smooth muscle cell proliferation. Hypertension. 1995;26:77-80.
25. 2 in mitogenesis of vascular smooth muscle cells. Agents Actions. 2003;48:42-62.
26. Wen Y, Nadler JL, Gonzales N, Scott S, Clauser E, Natarajan R. Mechanisms of Ang II-induced mitogenic responses: role of 12-lipoxygenase and biphasic MAP kinase. Am J Physiol Cell Physiol. 1996;71:C1212-C1220.
27. Benter IF, Diz DI, Ferrario CM. Cardiovascular actions of angiotensin-(1-7). Peptides. 1993;14:679-684.
28. Meng W, Busija DW. Comparative effects of angiotensin-(1-7) and angiotensin II on piglet pial arterioles. Stroke. 1993;24:2041-2045.
29. Iyer SN, Yamada K, Diz DI, Ferrario CM, Chappell MC. Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system. J Cardiovasc Pharmacol. 2000;36:109-117.
30. 1 and intracellular cAMP levels. Prostaglandins Leukot Essent Fatty Acids. 1996;54:101-107.
31. 2+ mobilization, by cyclic AMP and GMP in rabbit aortic smooth-muscle cells. Biochem J. 1992;288:527-532.
32. Indolfi C, Avvedimento EV, Di Lorenzo E, Esposito G, Rapacciuolo A, Giuliano P, Grieco D, Cavuto L, Stringone AM, Ciullo II, Condorelli G, Chiariello M. Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury. Nat Med. 1997;3:775-779.
33. Marrero MB, Schieffer B, Li B, Sun J, Harp JB, Ling BN. Role of Janus kinase/signal transducter and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle proliferation. J Biol Chem. 1997;272:24684-24690.
34. Bornfeldt KE, Campbell JS, Koyama H, Argast GM, Leslis CC, Raines EW, Krebs EG, Ross R. The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells dependent on the availability of downstream targets. J Clin Invest. 1997;100:875-885.
35. Graves LM, Bornfeldt KE. Raines EW, Potts BC, Macdonald SG, Ross R, Krebs EG. Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc Natl Acad Sci USA. 1993;90:10300-10304.
36. Kip1) of cyclin-dependent kinase 4. Cell. 1994;79:487-496.
37. Takeda-Matsubara Y, Nakagami H, Iwai M, Cui T-X, Shiuchi T, Akishita M, Nahmias C, Ito M, Horiuchi M. Estrogen activates phosphatases and antagonizes growth-promoting effect of angiotensin II. Hypertension. 2002;39:41-45.
38. Asada Y, Kisanuki A, Hatakeyama K, Takahama S, Koyama T, Kurozumi S, Sumiyoshi A. Inhibitory effects of prostacyclin analogue, TFC-132, on aortic neointimal thickening in vivo and smooth muscle cell proliferation in vitro. Prostaglandins Leukot Essent Fatty Acids. 1994;51:245-248.
39. Darius H, Nixdorff U, Zander J, Rupprecht H-J, Erbel R, Meyer J. Effects of ciprostene on restenosis rate during therapeutic transluminal coronary angioplasty. In: Sinzinger HF, Schrör K, eds. Prostaglandins in the Cardiovascular System. Boston, Mass: Birkhauser-Verlag; 1992:305-311.
40. Kurisu Y, Orihashi K, Sueda T, Kajihara H, Matsuura Y. Protective effect of beraprost sodium, a stable prostacyclin analogue, on cardiac allograft vasculopathy in rats. Hiroshima J Med Sci. 1997;46:11-19.
41. Ii M, Hoshiga M, Fukui R, Negoro N, Nakakoji T, Nishiguchi F, Kohbayashi E, Ishihara T, Hanafusa T. Beraprost sodium regulates cell cycle in vascular smooth muscle cells through cAMP signaling by preventing down-regulation of p27(Kip1). Cardiovasc Res. 2001;52:500-508.
42. Indolfi C, DiLorenzo E, Rapacciuolo A, Stingone AM, Stabile E, Leccia A, Torella JD, Caputo R, Cardiello F, Tortora G, Chiariello M. 8-Chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo. J Am Coll Cardiol. 2000;36:288-293.
43. Hu Y, Cheng L, Hochleitner B-W, Xu Q, Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arterioscler Thromb Vasc Biol. 1997;17:2808-2816.
44. 2-terminal kinase prevents neointimal formation in balloon-injured rat artery. Circ Res. 2001;88:1120-1126.
45. Indolfi C, Avvedimento EV, Rapacciuolo A, Esposito G, Di Lorenzo E, Leccia A, Pisani A, Chieffo A, Coppola A, Chiariello M. In vivo gene transfer: prevention of neointima formation by inhibition of mitogen-activated protein kinase kinase. Basic Res Cardiol. 1997;92:378-384.
46. Liu B, Fisher M, Groves P. Down-regulation of the ERK1 and ERK2 mitogen-activated protein kinases using antisense oligonucleotides inhibits intimal hyperplasia in a porcine model of coronary balloon angioplasty. Cardiovasc Res. 2002;54:640-648.
47. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, Oliveira-dos-Santos AJ, da Costa J, Zhang L, Pei Y, Scholey J, Ferrario CM, Manoukian AS, Chappell MC, Backx PH, Yogil Y, Penninger JM. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417:822-828.